News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan (MYL)'s Chairman Made Nearly $100 Million Last Year Despite EpiPen Controversy



5/3/2017 6:54:27 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Mylan NV disclosed that its chairman received nearly $100 million last year, among the largest pay packages disclosed this year for any public company, even as the drugmaker was buffeted in 2016 by a public furor over hefty price increases on its lifesaving EpiPen.

The disclosed pay for Robert J. Coury doesn’t include an additional $66.3 million in retirement benefits and other payments that Coury received last year in connection with what Mylan called his transition from executive chairman to a nonemployee chairman role.

Read at Market Watch
Read at Post-Gazette
Read at Chicago Tribune
Read at Business Insider
Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES